Capital Ideas
Morning NoteGet Premium


Valens Strikes a Deal with Canopy

Keep reading for news on Valens GroWorks (CSE:VGW), a bear turning more positive on GE, bottom fishing for semiconductors, and a way to play hemp legalization in the U.S.

Initiations & Upgrades

Rational advice on how to handle downturns. A biotech developing synthetic CBD treatments with 245% upside. And a utility stock breaking out to an all-time high.

Biotech Leads CBD Race

Today’s Digest will feature clear-eyed investment advice, a stock investors are flocking to, and a biotech working on CBD treatments with huge upside.

Prescient Prediction from Cronos CEO

Cronos Group CEO Michael Gorenstein gave us his prognostication on consolidation in the cannabis sector earlier this year. Cronos shares are nearly 40% higher since.

Fabrice Taylor Questioned Aphria’s Investment Activities 18 Months Ago on Capital Ideas TV

Capital Ideas contributor Fabrice Taylor dissected Aphria’s trading in June of 2017. See Taylor’s analysis of Aphria’s activities and the response of company CEO Vic Neufeld.

Rough Open, Canopy Deal & New CEO Video

Hear about the strategy shift Peekaboo Beans has implemented to “supercharge” growth. And look out for an interview with the CEO of a cannabis company building a global footprint.

Already Up 1,000% in Three Years & Still Could Gain 140%.

Coverage of a stock that could add to its 1,000% gain. The new Digest on a company with takeout potential. Watch the replay of our live interview with Kintavar’s CEO.

Software Stock Set to Soar; Live Interview Today.

Catch our live show today at 2 pm ET with Kiril Mugerman, CEO of Kintavar Exploration (TSXV:KTR). Today’s Digest features research on a software company set to soar again.

Error X
Your e-mails don't match.